Dio Tree
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Wadi Al-haj, Nazareth, IsraelWebsite
www.dio-tree.comRevenue
<$5 MillionIndustry
About Dio Tree
Dio Tree Org Chart
Is Dio Tree your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Dio Tree
Check out if Dio Tree is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Dio Tree, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Dio Tree recently announced quarterly report
Check if Dio Tree has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Dio Tree launches new products
Funding: Get notified immidiatlly once Dio Tree has new funding data
Click to see if Dio Tree had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Dio Tree as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Dio Tree is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dio Tree is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dio Tree.
Dio Tree Tech Stack
A closer look at the technologies used by Dio Tree
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dio Tree
Dio Tree is dedicated to developing innovative treatments for high grade serous ovarian cancer (HGSOC) using a novel small molecule technology that targets the DIO3 enzyme, which is crucial in cancer progression. The company aims to provide hope to ovarian cancer patients, including those who are non-BRCA mutation carriers or resistant to existing... Read More